For instance, low expression in tumor cells of adaptors that control TK catalytic activity, such as MIG6, might predict heightened oncogenic signaling dependent of deregulated TKs, such as ERBB receptors, and therefore may be a good predicator of tumor cell response to TK inhibitors (TKIs) (Figure 5). This evidence concerns the gene TKT and neoplasm.